JP2022536669A5 - - Google Patents
Info
- Publication number
- JP2022536669A5 JP2022536669A5 JP2021573344A JP2021573344A JP2022536669A5 JP 2022536669 A5 JP2022536669 A5 JP 2022536669A5 JP 2021573344 A JP2021573344 A JP 2021573344A JP 2021573344 A JP2021573344 A JP 2021573344A JP 2022536669 A5 JP2022536669 A5 JP 2022536669A5
- Authority
- JP
- Japan
- Prior art keywords
- risdiplam
- midazolam
- pharmaceutical composition
- patients
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19179563 | 2019-06-12 | ||
| EP19179563.2 | 2019-06-12 | ||
| PCT/EP2020/066003 WO2020249577A1 (en) | 2019-06-12 | 2020-06-10 | New treatment of sma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022536669A JP2022536669A (ja) | 2022-08-18 |
| JP2022536669A5 true JP2022536669A5 (https=) | 2023-06-16 |
Family
ID=66826852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573344A Pending JP2022536669A (ja) | 2019-06-12 | 2020-06-10 | Ｓｍａの新規治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220168307A1 (https=) |
| EP (1) | EP3982970A1 (https=) |
| JP (1) | JP2022536669A (https=) |
| CN (1) | CN113966219A (https=) |
| WO (1) | WO2020249577A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4197536A1 (en) * | 2021-12-20 | 2023-06-21 | Universitat de València | Haloperidol for use in the treatment of spinal muscular atrophy |
| CN117250301B (zh) * | 2023-11-20 | 2024-02-09 | 中国医学科学院北京协和医院 | 一种定量检测人血浆中诺西那生的液相质谱联用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130964D0 (en) | 2001-12-24 | 2002-02-13 | Special Products Ltd | Pharmaceutical composition |
| SI3143025T1 (sl) | 2014-05-15 | 2020-01-31 | F. Hoffmann-La Roche Ag | Spojine za zdravljenje spinalne mišične atrofije |
| JP6659841B2 (ja) | 2015-11-12 | 2020-03-04 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 脊髄性筋萎縮症を処置するための組成物 |
| KR102761837B1 (ko) * | 2017-10-03 | 2025-02-05 | 에프. 호프만-라 로슈 아게 | 척수성 근위축증의 새로운 치료법 |
-
2020
- 2020-06-10 CN CN202080043043.1A patent/CN113966219A/zh active Pending
- 2020-06-10 WO PCT/EP2020/066003 patent/WO2020249577A1/en not_active Ceased
- 2020-06-10 EP EP20734116.5A patent/EP3982970A1/en not_active Withdrawn
- 2020-06-10 JP JP2021573344A patent/JP2022536669A/ja active Pending
-
2021
- 2021-12-10 US US17/548,352 patent/US20220168307A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2176507C2 (ru) | Пероральные жидкие композиции, содержащие алендронат | |
| ES2626134T3 (es) | Composiciones de bepotastina | |
| JP6353577B2 (ja) | 組み合わせ組成物 | |
| JP2006518751A (ja) | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 | |
| EP3003384B1 (en) | Oral solution comprising atomoxetine hydrochloride | |
| ES2333805T3 (es) | Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos. | |
| JP2008512453A (ja) | 胃酸の急速かつ持続的な抑制のための製剤、オメプラゾール制酸剤複合体−即時放出物 | |
| SK146297A3 (en) | Composition comprising amoxycillin and clavulanic acid | |
| CN120091814A (zh) | 用slc6a19功能的哌啶抑制剂治疗pku的给药方案 | |
| CA2350857A1 (en) | The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease | |
| IL323792A (en) | New treatment of sma | |
| ES2763437T3 (es) | Composición para el tratamiento de la esterilidad | |
| JP2022536669A5 (https=) | ||
| CN110869003A (zh) | 一种不含防腐剂的固体剂型氨己烯酸药物组合物 | |
| US8153824B2 (en) | Antidepressant oral liquid compositions | |
| US6008222A (en) | Method for oral administration of buspirone and nefazodone | |
| IL276838A (en) | Oral formulation and suspension of an oncology drug | |
| CN115227658A (zh) | 一种氨己烯酸固体制剂组合物 | |
| WO2013173803A2 (en) | Formulations of amoxicillin and clavulanate potassium and methods for using same | |
| JP7270901B2 (ja) | 男性の避妊のための非ホルモン性組成物および方法 | |
| JP2025026838A (ja) | レボケトコナゾールによる疾患の処置方法 | |
| JP2022549833A5 (https=) | ||
| WO2020155507A1 (zh) | 一种不含防腐剂的固体剂型氨己烯酸药物组合物 | |
| CN1372468A (zh) | 羟乙磷酸二钠口服制剂 | |
| CN111511222B (zh) | 用于钙补充的组合物 |